New hope for adult leukemia patients: testing a powerful drug combination
NCT ID NCT07495631
Summary
This study is testing a new treatment approach for adults with a type of blood cancer called acute lymphoblastic leukemia (ALL). It combines a chemotherapy regimen designed for children with two newer types of drugs: venetoclax and immunotherapy. The goal is to see if this combination can better control the disease and improve survival for patients aged 14 to 60.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA, ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.